References
- World Health Organization. Situation Update of Dengue in the SEA Region, 2010. http://www.searo.who.int/LinkFiles/Dengue_Dengue_update_SEA_2010.pdf
- World Health Organization. Dengue Guidelines for Diagnosis, Treatment, Prevention and Control. Geneva: WHO, 2009.
- World Health Organization. Dengue Hemorrhagic Fever: Diagnosis, Treatment, Prevention and Control, 2nd edn. Geneva: WHO, 1997.
- Greenberg PL, Gordeuk V, Issaragrisil S, Siritanaratkul N, Fucharoen S, Ribeiro RC. Major hematologic diseases in the developing world — new aspects of diagnosis and management of thalassemia, malarial anemia, and acute leukemia. Hematology Am Soc Hematol Educ Program. 2001:479–98.
- Pongtanakul B, Narkbunnam N, Veerakul G, Sanpakit K, Viprakasit V, Tanphaichitr VT, et al.. Dengue hemorrhagic fever in patients with thalassemia. J Med Assoc Thai. 2005;88 (suppl 8):S80–5.
- Dinand V, Metzler V, Yadav SP, Sachdeva A. Atypical dengue fever in a splenectomized boy with glucose-6-phosphodehydrogenase deficiency and thalassemia intermedia. Indian J Pediatr. 2011;78:482–4.
- Chuansumrit A, Wangruangsatid S, Lektrakul Y, Chua MN, Zeta Capeding MR, Bech OM, et al.. Control of bleeding in children with dengue hemorrhagic fever using recombinant activated factor VII: a randomized, double-blind, placebo-controlled study. Blood Coagul Fibrinolysis. 2005;16:549–55.
- Chuansumrit A, Puripokai C, Butthep P, Wongtiraporn W, Sasanakul W, Tangnararatchakit K, et al.. Laboratory predictors of dengue shock syndrome during the febrile stage. Southeast Asian J Trop Med Public Health. 2010;41:326–32.
- Tantracheewathorn T, Tantracheewathorn S. Risk factors of dengue shock syndrome in children. J Med Assoc Thai. 2007;90:272–7.
- Tanphaichitr VS, Chonlasin R, Suwantol L, Pung-Amritt P, Tachavanich K, Yogsan S, et al.. Effect of red blood cell glucose-6-phosphate dehydrogenase deficiency on patients with dengue hemorrhagic fever. J Med Assoc Thai. 2002; 85 (suppl 2):S522–9.
- Cunningham MJ, Sankaran VG, Nathan DG, Orkin SH. The thalassemias. In: , Orkin S H, Nathan D G, Ginsberg D, Look A T, Fisher D E, Lux S E, Nathan and Oski’s Hematology of Infancy and Childhood, 7th edn. Philadelphia, PA: Saunders Elsevier, 2009; 1015.
- Pancharoen C, Thisyakorn U. Coinfections in dengue patients. Pediatr Infect Dis J. 1998;17:81–2.
- Basuki PS, Budiyanto, Puspitasari D, Husada D, Darmowandowo W, Ismoedijanto, et al.. Application of revised dengue classification criteria as a severity marker of dengue viral infection in Indonesia. Southeast Asian J Trop Med Public Health. 2010;41:1088–94.
- Sonntago O. Haemolysis as an interference factor in clinical chemistry. J Clin Chem Clin Biochem. 1986;24:127–39.
- Nsiah K, Dzogbefia VP, Ansong D, Akoto AO, Boateng H, Ocloo D. Pattern of AST and ALT changes in relation to hemolysis in sickle cell disease. Clin Med Insights Blood Disorders. 2011;4:1–9.
- Trung DT, Thao le TT, Hien TT, Hung NT, Vinh NN, Hien PT, et al.. Liver involvement associated with dengue infection in adults in Vietnam. Am J Trop Med Hyg. 2010;83:774–80.
- Chuansumrit A, Phimolthares V, Tardtong P, Tapaneya-Olarn C, Tapaneya-Olarn W, Kowsathit P, et al.. Transfusion requirements in patients with dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health. 2000;31:10–14.